Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2011;42:e26]. Stroke. 2011;42:517 584. Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other Jo-Ann Eastwood University of California Los Angeles AHA None Preventive Cardiovascular Nurses: Expert exchange* None None None None Michael D. Hill University of Calgary Covidien (money goes to institution); Hoffmann-La Roche Canada (money goes to institution) Heart & Stroke Foundation Alberta (money goes to institution); Alberta Innovates Health Solutions (money goes to institution) None None None Merck Ltd.* None Marian Limacher University of Florida NIH None None None None None None Virginia Miller Mayo Clinic None None None None None None None Latha Stead University of Florida None None None None None None None Greg Zipfel Washington University NINDS ; AHA ; Brain Aneurysm Foundation*; Hope Center for Neurological Disorders*; Pfizer None None None None Pfizer* None This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be significant if (1) the person receives $10000 or more during any 12-month period, or 5% or more of the person s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition. *Modest. Significant. 20. 